Dr. Johnson Truong is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent and innovations practice. His technical expertise spans across variety of fields including organic chemistry, material science, and polymer chemistry. Johnson applies his experience to management of patent portfolios, patent prosecution, freedom-to-operate, and due diligence matters for clients in life sciences, nanotechnology, biotechnology, small molecules, and pharmaceutical formulations
Dr. Johnson Truong is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent and innovations practice. His technical expertise spans across variety of fields including organic chemistry, material science, and polymer chemistry. Johnson applies his experience to management of patent portfolios, patent prosecution, freedom-to-operate, and due diligence matters for clients in life sciences, nanotechnology, biotechnology, small molecules, and pharmaceutical formulations
- Ph.D., Chemistry, Georgetown University, 2020
- B.S., Chemistry, University of Rochester, 2015
- U.S. Patent and Trademark Office
- Ph.D., Chemistry, Georgetown University, 2020
- B.S., Chemistry, University of Rochester, 2015
- U.S. Patent and Trademark Office
Select Publications
-
Co-author, “Elucidation of Strain-Dependent, Zinc Oxide Nanorod Response for Nanorod-Guided Fluorescence Intensity,” 12(20) Nanomaterials 3558-3571, 2022
- Co-author, “Recent advances towards single biomolecule level understanding of protein adsorption phenomena unique to nanoscale polymer surfaces with chemical variations,” 13(5) Nano Research 1295-1317, 2020
- Co-author, “Position- and polarization-specific waveguiding of multi-emissions in single ZnO nanorods,” 6(6) ACS Photonics 1416-1424, 2019
- Co-author, “Single nanomaterial level investigation of ZnO nanorod sulfidation reaction via position resolved confocal Raman spectroscopy,” 11(3) Nanoscale 1147-1158, 2019
- Co-author, “Spatially correlated, single nanomaterial-level, structural and optical profiling of Cu-doped ZnO nanorods synthesized via multifunctional silicides,” 8(4) Nanomaterials 222-234, 2018
- Co-author, “Distinct Raman scattering characteristics of individual ZnO nanorods under controlled polarization: Intense end scattering from forbidden modes,” 9(24) Nanoscale 8470-8480, 2017
- Co-author, “Polarization-resolved mechanistic investigation of fluorescence signal intensification on zinc oxide nanorod ends,” 9(24) Nanoscale 8164-8175, 2017
- Co-author, “Emerging cytokine biosensors with optical detection modalities and nanomaterial enabled signal enhancement,” 17(2) Sensors 428-473, 2017
Select Publications
-
Co-author, “Elucidation of Strain-Dependent, Zinc Oxide Nanorod Response for Nanorod-Guided Fluorescence Intensity,” 12(20) Nanomaterials 3558-3571, 2022
- Co-author, “Recent advances towards single biomolecule level understanding of protein adsorption phenomena unique to nanoscale polymer surfaces with chemical variations,” 13(5) Nano Research 1295-1317, 2020
- Co-author, “Position- and polarization-specific waveguiding of multi-emissions in single ZnO nanorods,” 6(6) ACS Photonics 1416-1424, 2019
- Co-author, “Single nanomaterial level investigation of ZnO nanorod sulfidation reaction via position resolved confocal Raman spectroscopy,” 11(3) Nanoscale 1147-1158, 2019
- Co-author, “Spatially correlated, single nanomaterial-level, structural and optical profiling of Cu-doped ZnO nanorods synthesized via multifunctional silicides,” 8(4) Nanomaterials 222-234, 2018
- Co-author, “Distinct Raman scattering characteristics of individual ZnO nanorods under controlled polarization: Intense end scattering from forbidden modes,” 9(24) Nanoscale 8470-8480, 2017
- Co-author, “Polarization-resolved mechanistic investigation of fluorescence signal intensification on zinc oxide nanorod ends,” 9(24) Nanoscale 8164-8175, 2017
- Co-author, “Emerging cytokine biosensors with optical detection modalities and nanomaterial enabled signal enhancement,” 17(2) Sensors 428-473, 2017
The acquisition brings together companies with complementary strengths, enhancing Azurity’s ability to realize its purpose of Serving Overlooked Patients. The combined development portfolios are expected to yield a significant number of new medicine launches over the coming years.
The Wilson Sonsini team that advised Azurity on IP matters related to the acquisition includes Clark Lin, Wendy Devine, Ying Chen, Shu Boboila, Xiaoyang Tang, Kevin Tylock, and Johnson Truong.
- Privacy Policy
- Terms of Use
- Accessibility